Device type · LKK
Pump, Infusion, Implanted, Programmable
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
LKK
General Hospital
Device class
Class III
FDA decisions since 2015
2
510(k), De Novo and PMA
Adverse event reports
6,328
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Pump, Infusion, Implanted, Programmable
- Product code
- LKK
- Device class
- Class III
- Review panel
- General Hospital
- Specialty
- Hospital Medicine & Nursing
- FDA record
- Classification database entry for LKK
Latest FDA decisions
- Prometra Programmable Infusion Pump SystemPMA supplement
P080012-S068 · Decided Jan 12, 2022 · 433 days after receipt · Panel Track
Device type: Pump, infusion, implanted, programmable (LKK) · Hospital Medicine & Nursing
P140032 · Decided Dec 22, 2017 · 1,095 days after receipt
Device type: Pump, infusion, implanted, programmable (LKK) · Hospital Medicine & Nursing
Reports received
6,328
Received Nov 1, 2025 to Nov 19, 2026. Includes 16 of another or unstated type.
Malfunction reports
3,872
61% of reports
Injury reports
2,426
38% of reports
Death reports
14
0.2% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 81 | 204 | 0 | 0 |
| Jan 24 | 103 | 245 | 0 | 0 |
| Feb 24 | 141 | 215 | 1 | 0 |
| Mar 24 | 138 | 247 | 1 | 0 |
| Apr 24 | 126 | 252 | 3 | 0 |
| May 24 | 131 | 256 | 0 | 0 |
| Jun 24 | 176 | 235 | 2 | 0 |
| Jul 24 | 184 | 255 | 1 | 0 |
| Aug 24 | 185 | 196 | 0 | 0 |
| Sep 24 | 151 | 228 | 0 | 0 |
| Oct 24 | 212 | 232 | 0 | 0 |
| Nov 24 | 135 | 194 | 0 | 0 |
| Dec 24 | 183 | 191 | 0 | 0 |
| Jan 25 | 165 | 202 | 0 | 0 |
| Feb 25 | 431 | 192 | 0 | 0 |
| Mar 25 | 237 | 234 | 1 | 0 |
| Apr 25 | 245 | 228 | 2 | 1 |
| May 25 | 265 | 211 | 1 | 0 |
| Jun 25 | 287 | 243 | 0 | 0 |
| Jul 25 | 262 | 212 | 0 | 0 |
| Aug 25 | 254 | 195 | 0 | 0 |
| Sep 25 | 296 | 235 | 0 | 0 |
| Oct 25 | 343 | 235 | 0 | 0 |
| Nov 25 | 241 | 186 | 0 | 1 |
| Dec 25 | 236 | 176 | 0 | 0 |
| Jan 26 | 292 | 192 | 1 | 0 |
| Feb 26 | 665 | 165 | 2 | 0 |
| Mar 26 | 503 | 236 | 1 | 0 |
| Apr 26 | 293 | 210 | 0 | 0 |
| May 26 | 251 | 202 | 1 | 0 |
| Jun 26 | 309 | 172 | 1 | 0 |
| Jul 26 | 277 | 209 | 0 | 0 |
| Aug 26 | 238 | 228 | 2 | 5 |
| Sep 26 | 316 | 219 | 3 | 7 |
| Oct 26 | 251 | 231 | 3 | 3 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
- Medtronic6,152
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Communication or Transmission Problem2,373
- Adverse Event Without Identified Device or Use Problem1,148
- Insufficient Device Problem Information758
- Infusion or Flow Problem589
- Insufficient Flow or Under Infusion510
- Application Program Problem389
- Migration or Expulsion of Device373
- Obstruction of Flow336
- Material Integrity Problem332
- Charging Problem313
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions4,419
- Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available608
- Pain554
- Insufficient Information432
- Unspecified Infection302
- Muscular Rigidity144
- Seroma117
- Cerebrospinal Fluid Leakage115
- Discomfort84
- Headache81
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Intera Oncology INTERA 3000 Hepatic Artery Infusion Pump, AP-0300H, implantable drug delivery deviceCompleted
Z-2580-2026 · Started May 11, 2026 · Posted by FDA Jun 25, 2026
Reason given: There is the potential for leakage along the drug pathway from the pump through the end of the catheter.
Cause as FDA categorized it: Process control
Z-2201-2026 · Started Apr 8, 2026 · Posted by FDA May 14, 2026
Reason given: Software issue: When programming the SynchroMed Pump with the A810 CP App in Flex Infusion Mode, the infusion steps should automatically be arranged in consecutive order, from earliest to latest. However, in rare cases, the steps may be displayed out of order. If this occurs, the programmed Flex Infusion schedule will...
Cause as FDA categorized it: Under Investigation by firm
- A820 myPTM Software Application associated with Medtronic SynchroMed Pump and Infusion System.Open, Classified
Z-1506-2025 · Started Jan 9, 2025 · Posted by FDA Apr 1, 2025
Reason given: Product complaints were received describing the A820 myPTM app taking longer than expected for patients to interact with their implantable pump.
Cause as FDA categorized it: Under Investigation by firm
Z-0771-2025 · Started Nov 21, 2024 · Posted by FDA Dec 27, 2024
Reason given: Software issues were identified in application version 2.x.
Cause as FDA categorized it: Under Investigation by firm
Z-0772-2025 · Started Nov 21, 2024 · Posted by FDA Dec 27, 2024
Reason given: Software issues were identified in application version 2.x.
Cause as FDA categorized it: Under Investigation by firm
Z-0773-2025 · Started Nov 21, 2024 · Posted by FDA Dec 27, 2024
Reason given: Software issues were identified in application version 2.x.
Cause as FDA categorized it: Under Investigation by firm
Z-0774-2025 · Started Nov 21, 2024 · Posted by FDA Dec 27, 2024
Reason given: Software issues were identified in application version 2.x.
Cause as FDA categorized it: Under Investigation by firm
- SynchroMed II Infusion Pump. Product Number: 8637-20Open, Classified
Z-0137-2025 · Started Sep 11, 2024 · Posted by FDA Oct 21, 2024
Reason given: Potential for error and inability to interrogate pump due to data corruption in the pump memory.
Cause as FDA categorized it: Device Design
Showing the 8 newest of 132 recall records in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.